About Sequenom
Sequenom is a company based in San Diego (United States) founded in 1994 was acquired by LabCorp in July 2016. Sequenom has completed 1 acquisition, including Sensigen. Sequenom offers products and services including Genetic Testing, At-Home Kits, and Clinical Trial Testing. Sequenom operates in a competitive market with competitors including Natera, BillionToOne, Progenity, SYNLAB and Beikang Medical, among others.
Products & Services of Sequenom
Sequenom offers a comprehensive portfolio of products and services, including Genetic Testing, At-Home Kits, and Clinical Trial Testing.
Services for hereditary disease detection and analysis
Kits for self-collection and remote diagnostic testing
Testing support for biopharma and medical research
Apps and channels of Sequenom
its YouTube channel Labcorp has 6.37K subscribers and 30 videos.
Videos from Sequenom
The most watched videos on Sequenom's YouTube channel, Labcorp (6.37K subscribers). Click a video to play it here.
More on Labcorp .
Funding Insights of Sequenom
- Total Rounds 10
- Last Round Debt – Conventional — $85M
- First Round $4.43M
(Jan 2003)
All 10 funding rounds of Sequenom with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2015 | $85M | Debt – Conventional | – | – | – |
| May 2010 | $51.61M | Post-IPO | – | – | – |
| Dec 2009 | $1.51M | Post-IPO | – | – | – |
| Mar 2009 | $1.94M | Post-IPO | – | – | – |
| Jun 2008 | $3.6M | Post-IPO | – | – | – |
| Nov 2007 | $30.45M | Post-IPO | – | – | – |
| Jun 2006 | $27.38M | Post-IPO | – | – | – |
| Jun 2006 | $33M | Post-IPO | – | – | – |
| Sep 2005 | $132,000 | Post-IPO | – | – | – |
| Jan 2003 | $4.43M | Post-IPO | – | – | – |
1 investors in total: 1 institutional.
Investors in Sequenom
Sequenom has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include LabCorp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of laboratory tests for physicians | 1969 | labcorp.com | Burlington, United States |
Investor details for Sequenom
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sequenom
Sequenom has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Sensigen.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Women's health and genetic testing services are provided with support. | sensigen.com | Research Triangle Park, United States | 2002 | Jan 2009 | $8.7M |
Complete acquisition details for Sequenom
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Sequenom
6 dated milestones of Sequenom across 22 years, from founding to its latest funding, stage changes and deals.
Competitors of Sequenom
Sequenom operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, BillionToOne, Progenity, SYNLAB and Beikang Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| natera.com | 2004 | Redwood, United States | $152.1M | 3,293 | Developer of cell-free DNA testing for oncology, women’s health, and organ health | |
| billiontoone.com | 2015 | San Francisco, United States | $388.62M | 47 | Provider of cell-free cancer liquid biopsy test | |
| progenity.com | 2011 | San Diego, United States | $216.63M | 125 | Non-invasive prenatal genomic testing is provided for genetic disorders. | |
| synlab.com | 1998 | Munich, Germany | – | 28,693 | Provider of medical diagnosis and clinical laboratory analysis services | |
| basecare.cn | 2010 | Suzhou, China | $36.52M | – | NGS-based diagnostic solutions for neonatal screening are developed. | |
| yourgene-health.com | 2000 | Manchester, United Kingdom | – | 2 | Non-invasive prenatal genetic tests and genomic services are provided. | |
| pictordx.com | 2005 | Auckland, New Zealand | $11.1M | – | Immunodiagnostic products are developed via multiplexed assays. | |
| identifai-genetics.com | 2020 | Tel Aviv, Israel | $9.8M | – | Non-invasive prenatal screening for genetic syndromes is provided. | |
| berrygenomics.com | 2010 | Beijing, China | $16M | – | Next-generation sequencing solutions for genetic and oncology testing are developed. |
Detailed competitors of Sequenom
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sequenom
Websites that share an audience with Sequenom (sequenom.com).
Websites whose visitors overlap most with Sequenom. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| illumina.com | 100% | 672.7K | #61,793 | View details | |
| appliedbiosystems.com | 78% | – | – | View details | |
| affymetrix.com | 76% | 1.1K | #9,164,392 | View details | |
| collateralthx.com | 75% | – | – | View details | |
genetherapysystems.com | genetherapysystems.com | 75% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for Sequenom
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Sequenom
Complete news archive for Sequenom
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Sequenom
10 companies that operate in the same segment as Sequenom (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sequenom
Sequenom was founded in 1994 and raised its 1st funding round 9 years after it was founded.
Sequenom is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Sequenom was established in 1994 in San Diego, United States, within the biotechnology sector. Noninvasive prenatal testing is delivered through circulating cell-free fetal nucleic acids. Laboratory-developed tests for prenatal diseases and conditions are developed and commercialized. Operations center on genetic diagnostics in healthcare, with services targeted at prenatal screening needs across the region.
Sequenom's top competitors include Natera, BillionToOne and Pictor.
Sequenom offers Genetic Testing, At-Home Kits, and Clinical Trial Testing.
Sequenom has made 1 acquisition, including Sensigen.
Sequenom has 1 investor. Key investors include LabCorp.
Sequenom operates through Sequenom, Inc..
Yes. Sequenom was acquired by LabCorp in July 2016.